Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 13, 2014 07:01 ET | Source: TESARO, Inc.

TESARO and AnaptysBio Announce Collaboration and Exclusive Worldwide License Agreement for Multiple Immuno-Oncology Programs

Immuno-oncology platform provides a portfolio of candidates focused on high value targets, potentially augments the value of other pipeline candidates and enhances prospects for future...
March 06, 2014 08:01 ET | Source: TESARO, Inc.

TESARO to Present at the Barclays Global Healthcare Conference

WALTHAM, Mass., March 6, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Barclays Global Healthcare Conference in Miami on...
February 19, 2014 16:01 ET | Source: TESARO, Inc.

TESARO Announces Fourth-Quarter and Full-Year 2013 Operating Results

Oral Rolapitant New Drug Application on Track for Submission to U.S. FDA in Mid-2014 Niraparib Phase 3 NOVA and BRAVO Trials Continue to Advance Cash and Cash Equivalents Totaled...
February 07, 2014 08:01 ET | Source: TESARO, Inc.

TESARO to Announce Fourth Quarter 2013 Financial Results on February 19, 2014

WALTHAM, Mass., Feb. 7, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) will announce its fourth quarter 2013 financial results on Wednesday, February 19, 2014, after the close of the U.S....
February 05, 2014 16:01 ET | Source: TESARO, Inc.

TESARO to Present at Two Upcoming Investment Conferences

WALTHAM, Mass., Feb. 5, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will participate in...
January 29, 2014 22:45 ET | Source: TESARO, Inc.

TESARO Announces Pricing of Public Offering of Common Stock

WALTHAM, Mass., Jan. 29, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has priced an underwritten public offering of an aggregate of 3,200,000 shares of its common stock...
January 28, 2014 16:05 ET | Source: TESARO, Inc.

TESARO Announces Proposed Public Offering of Common Stock

WALTHAM, Mass., Jan. 28, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has commenced an underwritten public offering of $100 million of its common stock. In connection...
January 07, 2014 08:00 ET | Source: TESARO, Inc.

TESARO to Present at the 32nd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 7, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will attend the 32nd...
December 23, 2013 07:00 ET | Source: TESARO, Inc.

TESARO Announces Successful Achievement of Primary Endpoint in Each of Two Phase 3 Trials of Rolapitant for the Prevention of Chemotherapy-Induced Nausea & Vomiting (CINV)

A Phase 3 Trial in Patients Receiving Moderately Emetogenic Chemotherapy (MEC) Met the Primary Endpoint of Complete Response in the Delayed Period (24-120 Hours) Following Initiation of...
November 25, 2013 16:01 ET | Source: TESARO, Inc.

TESARO to Present at the 2013 Deutsche Bank BioFEST Conference

WALTHAM, Mass., Nov. 25, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will present at the...